Key statistics
As of last trade PureTech Health PLC (0VQ0:DUS) traded at 18.90, -9.13% below its 52-week high of 20.80, set on Nov 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.80 |
---|---|
High | 18.90 |
Low | 17.80 |
Bid | 20.40 |
Offer | 22.20 |
Previous close | 19.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 23.94m |
Free float | 2.70m |
P/E (TTM) | -- |
Market cap | 490.65m USD |
EPS (TTM) | -3.01 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:32 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- PureTech to Present at Two Upcoming Investor Conferences
- PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
- PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
- PureTech to Present at CHEST 2024 Annual Meeting
- PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
- PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
- PureTech Health plc – Half-Year Report
More ▼